QUARANTINE TRAILER RENTAL BUSINESS PLAN
Â
I. Executive Summary
Company Description
Containment Fleet LLC is named to signal two facts: we operate a mobile fleet and we specialize in bio-containment. Based in a major U.S. logistics hub, we operate in the medical logistics and emergency response sector, renting medically-compliant isolation trailers on an on-demand, OpEx basis. Our core product is a secure, climate-controlled quarantine trailer built to healthcare-grade standards and deployed with certified HVAC, negative-pressure capability, and standardized decontamination workflows.
We handle acquisition, fit-out, deployment, maintenance, and terminal decontamination through a specialized team of logistics and bio-containment experts. We serve hospitals, public health agencies, and industrial clients needing surge capacity. Short-term goal: field a 50-unit fleet and secure multi-month contracts with two regional hospital systems. Long-term goal: scale to a national network with regional hubs, add remote monitoring and modular upgrades, and convert 60–70% of revenue to recurring rental income. Competitive edge: full lifecycle service, medical compliance, and rapid deployment.
Â
Problem
Organizations lack secure, rapidly deployable isolation and quarantine capacity that meets medical bio-containment standards and can be activated within days. Permanent construction is too slow and often too expensive, while current temporary options fail to provide required containment, creating delays in patient isolation and testing, overloads on emergency care, and increased exposure and legal risk.
The market is underserved for a turnkey, on-demand OpEx solution that delivers medically-compliant, scalable quarantine space with end-to-end lifecycle management—acquisition, construction, rapid deployment, and decontamination—so responders, employers, and healthcare systems can maintain safety and operational continuity.
Â
Solution
Organizations lack a rapid, medically compliant way to expand isolation capacity during health or industrial crises—permanent construction is too slow and existing temporary options often fail containment standards. Our business provides a fleet of advanced, self-contained trailer units that deliver turnkey bio-containment and quarantine space on-site within days, meeting medical safety requirements and preserving staff and public safety.
Key features: HEPA filtration with negative-pressure airflow; integrated medical ventilators and independent power systems; specialized monitoring and alarm systems for continuous environmental and patient oversight; rapid transport and on-site setup for immediate use; professional decontamination and turnover for safe reuse; enables temporary capacity without permanent construction.
Â
Mission Statement
Our mission is to deliver immediate, medically-compliant isolation infrastructure that protects lives and ensures operational continuity for healthcare, government, and industrial partners. We commit to the highest standards of safety, rapid-response logistics, and turnkey service, providing reliable, scalable, and cost-effective mobile containment solutions. Through continual innovation and strict compliance, we mitigate risk and expand surge capacity across the United States.
Â
Key Success Factors
Critical operational, compliance, contractual, technical, and financial elements that must be met to scale the quarantine trailer rental business.
-
Rapid deployment capability enabled by the $135,000 transport truck and dedicated logistics team.
-
100% regulatory compliance with CDC, OSHA, and EPA to protect reputation and limit liability.
-
Long-term contracts and retainers via Master Service Agreements and standby retainers to secure revenue and high fleet utilization.
-
Technical readiness maintained by Bio-Containment Technicians operating the $95,000 industrial decontamination system.
-
Financial scalability demonstrated by achieving the projected EBITDA of $530,000 by 2028.
Financial Summary
The project launches in 2026 with an initial EBITDA loss, reaches breakeven in January 2028, and runs a six-unit fleet with steady EBITDA thereafter.
Â
Ratio |
2026 |
2027 |
2028 |
Projected Revenue |
 |
 |
 |
Projected EBITDA |
-$866,000 |
-$917,000 |
$530,000 |
Expected ROI |
0.01% (IRR) |
0.01% (IRR) |
0.01% (IRR) |
Â
Financial requirements: minimum cash position of $3,344,000 expected in Nov-2030; overall performance yields an IRR of 0.01% and ROE of 0.04% over five years, with full fleet sale on 31-Dec-2030.
The outlook shows early losses, a Jan-2028 breakeven, and stable operations at roughly $530,000 EBITDA in years three and four.
Â
Funding Requirements
We seek USD 2,140,000 in combined equity and asset-based financing to acquire two units, complete bio-containment work, buy essential equipment, and fund 25 months of fixed operations to breakeven.
Â
Categories |
Amount, USD |
Acquisitions (BioUnit Alpha + Containment X) |
500,000 |
Construction (bio-containment upgrades Alpha + X) |
100,000 |
Essential CapEx (truck, decontamination, IT, gear) |
385,000 |
Fixed operating expenses (25 months @ $46,200/month) |
1,155,000 |
 |
 |
 |
 |
Working capital |
1,155,000 |
Total funding required |
2,140,000 |
Â
Financial highlights: initial EBITDA (2026) = –$866,000; breakeven = January 2028; steady EBITDA in years 3–4 = $530,000; IRR (5-year) = 0.01%; ROE (5-year) = 0.04%; minimum cash = $3,344,000 by November 2030; final fleet sale = December 31, 2030.